Micardis 40mg Telmisartan Tablets 30s

Micardis 40mg Telmisartan Tablets 30s is a prescription cardiovascular medicine containing telmisartan 40mg in each tablet. Telmisartan belongs to a class of medicines known as angiotensin II receptor blockers, commonly abbreviated as ARBs.

Micardis 40mg is primarily used to treat essential hypertension, commonly known as high blood pressure, in adults. By helping blood vessels relax, telmisartan supports blood-pressure reduction and reduces the strain placed on the cardiovascular system.

Micardis may also have approved cardiovascular-risk reduction indications for selected high-risk adults. However, the recommended cardiovascular-prevention dose in the referenced product information is 80mg once daily. The 40mg strength should only be used for the indication and dosage specifically prescribed by the treating doctor.

Micardis 40mg Telmisartan Product Information

What Is Micardis 40mg Used For?

Essential Hypertension

Micardis 40mg is used to treat essential hypertension in adults. Essential hypertension refers to high blood pressure that does not have a single identifiable underlying cause.

High blood pressure often produces no noticeable symptoms. However, persistent uncontrolled hypertension can increase the strain placed on the heart, brain, kidneys and blood vessels.

Patients should continue taking Micardis according to their prescription and attend scheduled blood-pressure reviews even when they feel well.

Cardiovascular-Risk Reduction

Telmisartan may also be prescribed for cardiovascular-risk reduction in selected adults with established atherothrombotic cardiovascular disease or type 2 diabetes with documented target-organ damage.

The referenced professional product information recommends 80mg once daily for cardiovascular prevention. Micardis 40mg should therefore not be independently selected or promoted as the standard cardiovascular-prevention dose.

The treating doctor must determine whether cardiovascular-prevention treatment is appropriate and which strength should be used.

How Micardis Works

Angiotensin II is a naturally occurring substance that causes blood vessels to tighten. It can also contribute to sodium retention and increased blood pressure.

Telmisartan selectively blocks the action of angiotensin II at the AT₁ receptor. This helps blood vessels relax, reduces vascular resistance and supports lower blood pressure.

Micardis 40mg contains telmisartan as its only active ingredient. It does not contain a diuretic or water tablet.

How to Take Micardis 40mg

• Take Micardis exactly as prescribed by the treating doctor.
• The usually effective reference dose for adult hypertension is 40mg once daily.
• Some patients may require a different strength or treatment combination.
• Swallow the tablet whole with liquid.
• Micardis may be taken with or without food.
• Take the medicine at approximately the same time each day.
• Do not increase, reduce or stop treatment without medical advice.
• Do not take a double dose to compensate for a missed dose.
• Continue any diet, physical activity and blood-pressure monitoring plan recommended by the healthcare professional.

The maximum blood-pressure-lowering effect may take approximately four to eight weeks to develop after treatment begins or the dose is adjusted.

The dose must be individualised according to blood-pressure response, kidney function, liver function, hydration status, concurrent medicines and the prescribed indication.

Handling the Tablets

Telmisartan tablets can absorb moisture. Keep Micardis tablets in the sealed blister until shortly before each dose.

• Do not remove tablets from the blister for long-term storage in an open container.
• Do not use a tablet that appears wet, damaged, discoloured or deteriorated.
• Follow the storage and handling instructions printed on the supplied packaging.

Monitoring During Treatment

A healthcare professional may monitor the following before and during Micardis treatment:

• Blood pressure
• Kidney function
• Blood potassium levels
• Serum creatinine
• Fluid and hydration status
• Response to other antihypertensive medicines

Closer monitoring may be required in older adults, patients with kidney impairment, patients taking diuretics and those using other medicines that affect the renin-angiotensin-aldosterone system.

Important Safety Information

• Micardis is a prescription medicine and should not be shared with another person.
• Do not use Micardis during pregnancy.
• Inform the doctor immediately if pregnancy occurs or is suspected.
• Tell the prescriber about kidney disease, liver disease, biliary obstruction or narrowing of the kidney arteries.
• Tell the doctor about severe vomiting, diarrhoea, heavy sweating or reduced fluid intake.
• Rise slowly from sitting or lying positions if dizziness occurs.
• Do not drive or operate machinery when dizziness, faintness or reduced alertness is present.
• Do not take potassium supplements or potassium-containing salt substitutes unless advised by a healthcare professional.
• Attend scheduled blood tests and medical reviews.

Who Should Not Take Micardis?

Micardis may be contraindicated or unsuitable for patients with certain medical conditions. These include:

• Known allergy to telmisartan or another ingredient in the tablet
• Pregnancy
• Severe liver impairment
• Biliary obstructive disorders or cholestasis
• Certain combinations involving aliskiren in patients with diabetes or impaired kidney function

Additional caution may be necessary for patients with kidney impairment, renal artery stenosis, heart disease, low blood pressure, dehydration or elevated blood potassium.

Kidney Function and Potassium Levels

Medicines that affect the renin-angiotensin-aldosterone system can change kidney function and blood potassium levels in susceptible patients.

Additional monitoring may be required for patients who:

• Have kidney impairment
• Have narrowing of one or both kidney arteries
• Are significantly dehydrated
• Take potassium supplements
• Use potassium-sparing diuretics
• Regularly use non-steroidal anti-inflammatory medicines
• Use another ARB, an ACE inhibitor or aliskiren

Possible symptoms of elevated potassium may include unusual weakness, muscle discomfort, tingling sensations or an irregular heartbeat. High potassium may also occur without noticeable symptoms and may only be detected through a blood test.

Low Blood Pressure and Dehydration

Micardis may cause symptomatic low blood pressure, especially in patients who are significantly dehydrated or depleted of sodium.

The risk may increase during:

• Severe vomiting or diarrhoea
• Heavy sweating
• Reduced fluid intake
• Strict dietary salt restriction
• Intensive diuretic treatment
• Prolonged illness

Symptoms may include dizziness, weakness, blurred vision, light-headedness or fainting. Obtain medical advice when symptoms are persistent or severe.

Liver Considerations

Telmisartan is largely eliminated through the bile. Micardis must not be used in patients with severe liver impairment, cholestasis or biliary obstruction.

For patients with mild-to-moderate liver impairment, the referenced product information states that the dose should not exceed 40mg once daily.

A doctor must determine whether treatment is appropriate and whether additional monitoring is required.

Possible Side Effects

Not everyone experiences side effects. Possible effects associated with telmisartan include:

• Dizziness or light-headedness
• Low blood pressure
• Postural dizziness when standing
• Weakness or tiredness
• Increased blood potassium
• Changes in kidney-function test results
• Increased serum creatinine
• Abdominal discomfort
• Diarrhoea, indigestion or vomiting
• Back pain or muscle cramps
• Skin itching or rash

The likelihood and severity of side effects may vary according to the patient’s medical condition, concurrent medicines and treatment indication.

Serious Symptoms Requiring Medical Attention

Seek prompt or urgent medical attention if any of the following occurs:

• Swelling of the face, lips, tongue or throat
• Difficulty breathing or swallowing
• Fainting or severe dizziness
• Very low urine output
• Severe weakness or an irregular heartbeat
• Severe abdominal pain with nausea, vomiting or diarrhoea
• A severe, blistering or widespread skin reaction
• Another serious or unexpected reaction

Medicine Interactions

Tell the doctor and pharmacist about all prescription medicines, non-prescription products, traditional medicines and supplements being used.

Products requiring particular consideration include:

• ACE inhibitors, other ARBs or aliskiren: combined renin-angiotensin system blockade may increase the risk of low blood pressure, high potassium and impaired kidney function.
• Potassium supplements: blood potassium levels may increase.
• Potassium-containing salt substitutes: these may contribute to elevated potassium.
• Potassium-sparing diuretics: closer potassium and kidney-function monitoring may be required.
• Non-steroidal anti-inflammatory medicines: medicines such as ibuprofen, diclofenac and selective COX-2 inhibitors may reduce the blood-pressure-lowering effect and increase kidney risk in susceptible patients.
• Lithium: telmisartan may increase lithium concentrations and the risk of lithium toxicity.
• Digoxin: digoxin levels may increase and monitoring may be required.
• Other blood-pressure medicines or diuretics: combined treatment may increase the likelihood of low blood pressure.

Do not start, stop or change another medicine without consulting the treating doctor or pharmacist.

Pregnancy and Breastfeeding

Micardis should not be used during pregnancy. Medicines that act on the renin-angiotensin system may cause serious harm to a developing baby.

Patients who are pregnant, planning a pregnancy or think they may be pregnant should contact their doctor immediately. When pregnancy is diagnosed, telmisartan treatment should be stopped under medical direction and replaced with an appropriate alternative.

Micardis is not recommended during breastfeeding because sufficient information regarding telmisartan use during breastfeeding is unavailable. A doctor should recommend an alternative medicine with a better-established safety profile where appropriate.

Use in Children and Adolescents

The safety and effectiveness of Micardis in children and adolescents below 18 years old have not been established in the referenced product information.

Micardis 40mg should not be supplied to a child or adolescent unless specifically prescribed under the applicable Malaysian product information by an appropriate healthcare professional.

Storage Instructions

• Store according to the conditions printed on the carton and approved package insert.
• Keep the tablets in their original sealed blister packaging until required.
• Protect from excessive heat and moisture.
• Keep out of reach of children.
• Do not use tablets that appear damaged or deteriorated.
• Do not use after the expiry date printed on the supplied packaging.
• Product packaging, batch number and expiry date may vary between supplied batches.

Frequently Asked Questions

What is the active ingredient in Micardis 40mg?

Each Micardis 40mg tablet contains telmisartan 40mg.

What type of medicine is Micardis?

Micardis is an angiotensin II receptor blocker, commonly abbreviated as an ARB.

What is Micardis 40mg used for?

Micardis 40mg is primarily used to treat essential hypertension in adults. Telmisartan may also have approved cardiovascular-risk reduction indications, but the appropriate strength and dosage must be determined by the prescribing doctor.

Is Micardis a blood-pressure medicine?

Yes. Telmisartan helps lower blood pressure by blocking the effects of angiotensin II and allowing blood vessels to relax.

Is Micardis a diuretic or water tablet?

No. Micardis contains telmisartan as a single active ingredient and does not contain a diuretic.

What is the usual Micardis dose for hypertension?

The usually effective reference dose for adult essential hypertension is 40mg once daily. The actual prescribed dose may differ according to the patient’s blood-pressure response and clinical condition.

Can Micardis 40mg be used for cardiovascular prevention?

Telmisartan may be prescribed for cardiovascular-risk reduction in selected high-risk adults. However, the referenced professional product information recommends 80mg once daily for this indication. Patients must not independently substitute or combine strengths.

How long does Micardis take to lower blood pressure?

Blood-pressure reduction begins after treatment starts, but the maximum antihypertensive effect may take approximately four to eight weeks to develop.

Can Micardis be taken with food?

Yes. Micardis may be taken with or without food and should be swallowed whole with liquid.

Why should Micardis remain in its blister packaging?

Telmisartan tablets can absorb moisture. The tablet should remain in the sealed blister until shortly before it is taken.

Is Micardis 40mg a prescription medicine in Malaysia?

Yes. Micardis 40mg is a prescription medicine and should only be supplied and used according to a valid prescription and professional instructions.

What is the Malaysian registration number for Micardis 40mg?

The Malaysian product registration number is MAL19992673AZ.

Who manufactures Micardis 40mg?

The Malaysian product is manufactured by Boehringer Ingelheim Hellas Single Member S.A., Greece. The Malaysian registration holder is Boehringer Ingelheim (Malaysia) Sdn. Bhd.

How many tablets are supplied in one pack?

The P-Hub listing contains 30 tablets, supplied as three blister strips of 10 tablets.

Can Micardis increase potassium levels?

Yes. Telmisartan may increase blood potassium in some patients, particularly when combined with potassium supplements, potassium-containing salt substitutes or potassium-sparing medicines.

Can Micardis be used during pregnancy?

No. Micardis should not be used during pregnancy because medicines acting on the renin-angiotensin system may cause serious harm to a developing baby.

Can a patient stop Micardis when blood pressure improves?

No. High blood pressure frequently causes no noticeable symptoms. Do not stop Micardis unless instructed by the treating doctor, as blood pressure may rise again.

Can pharmacies request Micardis through P-Hub?

Micardis 40mg Telmisartan Tablets 30s is listed in the P-Hub B2B catalogue for approved pharmacy members. Quotation, ordering eligibility and supply are subject to P-Hub membership requirements, prescription medicine controls and current stock availability.

Prescription Medicine Notice

Micardis 40mg is a prescription medicine. It should only be supplied, dispensed and used according to applicable Malaysian requirements and the directions of a registered doctor or pharmacist.

The information on this page is provided for pharmacy catalogue and professional product-reference purposes. It does not replace an individual medical assessment, prescription, approved Malaysian package insert or advice from a qualified healthcare professional.

Product appearance, packaging, batch number, availability and expiry date may vary. Verify all information on the physical product packaging and approved insert before dispensing or use.

Product Information Sources

• 
  Boehringer Ingelheim – Micardis Product Overview
  
• 
  National Pharmaceutical Regulatory Agency Malaysia – Micardis Registration Renewal Record
  
• 
  Electronic Medicines Compendium – Micardis 40mg Professional Product Information
  

Product information last reviewed: 11 July 2026.